Hematology - Oncology Therapy

ISBN
9780071637893
$165.00
Author Boyiadzis, Michael M.
Format Trade Cloth
Details
  • 11.1" x 8.8" x 2.5"
  • Active Record
  • Individual Title
  • 2014
  • 1888
  • Yes
  • 4
  • RC633.A1H46 2012
Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment Regimens A Doody's Core Title for 2019 More than 500 treatment regimens Hematology-Oncology Therapy , Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniformmanner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive informationthat is critical to both office- and hospital-based practice of hematology and oncology. Hematology-Oncology Therapy is divided into three sections: Oncology: Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approvedchemotherapeutic regimens, drugs, and biological agents Supportive Care, Drug Preparation, Complications, and Screening: Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more Selected Hematologic Diseases: Delivers an authoritative guide to therapy for the principal diseases in consultative hematology This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.